Advertisement

Hepatitis B pp 215-224 | Cite as

Hepatitis B Surface Antigen Polypeptide and Synthetic Peptide Vaccines

  • G. R. Dreesman
  • I. Ionescu-Matiu
  • Y. Sanchez
  • R. C. Kennedy
  • J. T. Sparrow
  • J. L. Melnick

Abstract

The hepatitis B vaccine recently licensed for use in the United States has undergone several field trials in high-risk populations and has proven to be immunogenic, efficient and safe. The hepatitis vaccine is unique in that the hepatitis B virus (HBV), the ultimate source of the vaccine, cannot be grown in tissue culture. The immunizing antigen, purified from plasma of healthy human carriers of HBV, consists of noninfectious 22 nm particles of hepatitis B surface antigen (HBsAg), produced as excess viral surface protein and released in the bloodstream. Although the HBsAg particles are highly purified and inactivated, there is some concern that the vaccine may contain traces of host material or infective adventitious agents, which may trigger undesirable effects in the recipients. Ideally, a hepatitis B vaccine candidate should have the following properties: 1) be free of normal human serum protein contaminants, 2) be free of potential residual infectious HBV, 3) be free of other viruses and nucleic acid, 4) have a high degree of immunogenicity when administered in conjunction with an adjuvant suitable for use in humans, 5) be independent of human HBV carriers as a source of immunogenic material, 6) have a reproducible composition, 7) cost less than the present vaccine, and 8) be available in unlimited supplies.

Keywords

Booster Inoculation Primary Inoculation Free Thiol Group Viral Specific Protein Synthetic Peptide Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dreesman, G. R., Hollinger, F. B., McCombs, R. M., and Melnick, J. L. (1972). Infec. Immun. 5:213.Google Scholar
  2. 2.
    Cabrai, G. A., Marciano-Cabral, F., Funk, G. A., Sanchez, Y., Hollinger, F. B., Melnick, J. L., and Dreesman, G. R. (1978). J. Gen. Virol. 38:339.CrossRefGoogle Scholar
  3. 3.
    Sanchez, Y., Ionescu-Matiu, I., Hollinger, F. B., Melnick, J. L., and Dreesman, G. R. (1980). J. Gen. Virol. 48:273.PubMedCrossRefGoogle Scholar
  4. 4.
    Dreesman, G. R., Hollinger, F. B., Sanchez, Y., Oefinger, P., and Melnick, J. L. (1981). Infec. Immun. 32:62.Google Scholar
  5. 5.
    Dreesman, G. R., Hollinger, F. B., McCombs, R. M., and Melnick, J. L. (1973). J. Gen. Virol. 19:129.PubMedCrossRefGoogle Scholar
  6. 6.
    Tiollais, P., Charnay, P., and Vyas, G. N. (1981). Science 213:406.PubMedCrossRefGoogle Scholar
  7. 7.
    Sanchez, Y., Ionescu-Matiu, I., Melnick, J. L., and Dreesman, G. R. (1983). J. Med. Virol. 11:115.PubMedCrossRefGoogle Scholar
  8. 8.
    Simons, K., Helenius, A., Leonard, K., Sarvas, M., and Gething, M. J. (1978). Proc. Natl. Acad. Sci. USA 75:5306.PubMedCrossRefGoogle Scholar
  9. 9.
    Zuckerman, A. J., Howard, C. R., and Skelly, J. (1981). in Hepatitis B Vaccine, P. Maupas and P. Guesry, eds., Elsevier/North-Holland Biomedical Press, Amsterdam, p. 251.Google Scholar
  10. 10.
    Ionescu-Matiu, I., Sanchez, Y., Fields, H. A., and Dreesman, G. R. (1983). J. Virol. Methods 6:41.PubMedCrossRefGoogle Scholar
  11. 11.
    Charnay, P., Pourcel, C., Louise, A., Fritsch, A., and Tiollais, P. (1979). Proc. Natl. Acad. Sci. USA 76:2222.PubMedCrossRefGoogle Scholar
  12. 12.
    Valenzuela, P., Gray, P., Quiroga, M., Zaldivar, J., Goodman, A. M., and Rutter, W. J. (1979). Nature 280:815.PubMedCrossRefGoogle Scholar
  13. 13.
    Pasek, M., Gotto, T., Gilbert, W., Zink, B., Schaller, H., MacKay, P., Leadbetter, G., and Murray, K. (1979). Nature 282:575.PubMedCrossRefGoogle Scholar
  14. 14.
    Peterson, D. L. (1981). J. Biochem. 256:6975.Google Scholar
  15. 15.
    Bull, H. B. and Bresse, K. (1975). Arch. Biochem. Biophys. 161:665.CrossRefGoogle Scholar
  16. 16.
    Chou, P. Y. and Fasman, G. D. (1978). Adv. Enzym. 47:45.Google Scholar
  17. 17.
    Lerner, R. A., Green, N., Alexander, H., Liu, F.-T., Sutcliffe, J. G., and Shinnick, T. M. (1981). Proc. Natl. Acad. Sci. USA 78:3403.PubMedCrossRefGoogle Scholar
  18. 18.
    Bhatnagar, P. K., Papas, E., Blum, H. E., Milich, D. R., Nitecki, D., Karels, M. J., and Vyas, G. N. (1982). Proc. Natl. Acad. Sci. USA 79:4400.PubMedCrossRefGoogle Scholar
  19. 19.
    Prince, A. M., Ikram, H., and Hopp, T. P. (1982). Proc. Natl. Acad. Sci. USA 79:579.PubMedCrossRefGoogle Scholar
  20. 20.
    Dreesman, G. R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J. T., Six, H. R., Peterson, D. L., Hollinger, F. B., and Melnick, J. L. (1982). Nature 295:158.PubMedCrossRefGoogle Scholar
  21. 21.
    Sanchez, Y., Ionescu-Matiu, I., Sparrow, J. T., Melnick, J. L., and Dreesman, G. R. (1982). Intervirology 18:209.PubMedCrossRefGoogle Scholar
  22. 22.
    Kennedy, R. C., Ionescu-Matiu, I., Adler-Storthz, K., Henkel, R. D., Sanchez, Y., and Dreesman, G. R. (1983). Intervirology 19:176.PubMedCrossRefGoogle Scholar
  23. 23.
    Ionescu-Matiu, I., Kennedy, R. C., Sparrow, J. T., Culwell, A. R., Sanchez, Y., Melnick, J. L., and Dreesman, G. R. (1983). J. Immunol. 130:1947.PubMedGoogle Scholar
  24. 24.
    Peterson, D. L. (1982). in Viral Hepatitis, 1981 International Symposium, W. Szmuness, H. J. Alter and J. E. Maynard, eds., Franklin Institute Press, Philadelphia, p. 707.Google Scholar
  25. 25.
    Kennedy, R. C. and Dreesman, G. R. (1983). J. Immunol. 130:385.PubMedGoogle Scholar
  26. 26.
    Kennedy, R. C., Sanchez, Y., Ionescu-Matiu, I., Melnick, J. L., and Dreesman, G. R. (1982). Virology 122:219.PubMedCrossRefGoogle Scholar
  27. 27.
    Kennedy, R. C., Dreesman, G. R., Sparrow, J. T., Culwell, A. R., Sanchez, Y., Ionescu-Matiu, I., Hollinger, F. B., and Melnick, J. L. (1983). J. Virol. 46:653.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • G. R. Dreesman
    • 1
  • I. Ionescu-Matiu
    • 1
  • Y. Sanchez
    • 1
  • R. C. Kennedy
    • 1
  • J. T. Sparrow
    • 1
  • J. L. Melnick
    • 1
  1. 1.Department of Virology and EpidemiologyBaylor College of MedicineHoustonUSA

Personalised recommendations